Douglas M. Hunt - Sep 2, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Signature
/s/ Gordon Esplin as attorney-in-fact for Douglas M. Hunt
Stock symbol
PBYI
Transactions as of
Sep 2, 2022
Transactions value $
-$1,121
Form type
4
Date filed
9/7/2022, 04:40 PM
Previous filing
Aug 4, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale -$1.12K -433 -0.56% $2.59 76.9K Sep 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.565 to $2.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.